Search - tctmd.com

Displaying 221 - 240 of 264

Sort: Relevancy | Date

Presentation

Cerebrovascular Events in 21,105 Patients with A-fib Randomized to Edoxaban Versus Warfarin

Presenter: Robert P. Giugliano

June 24, 2014

News Daily News

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

L.A. McKeown

April 29, 2014

News Daily News

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

L.A. McKeown

April 22, 2014

Presentation ECHO 2014

Clinical Decision Making in Stroke and Atrial Fibrillation (Including Closure Devices)

Presenter: James D. Thomas

April 11, 2014

News Conference News ACC 2014

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Caitlin E. Cox

April 02, 2014

News Daily News

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

L.A. McKeown

March 27, 2014

News Daily News

Timeliness, Revascularization Improve Endovascular Therapy Outcomes for Acute Stroke

March 20, 2014

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

Presentation

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Presenter: Paul Dorian

February 20, 2014

News Daily News

Cooling Protocol Feasible, Safe in Acute Stroke Patients

L.A. McKeown

February 03, 2014

News Daily News

Balloon Guide Catheter Improves Acute Stroke Outcomes as Adjunct to Stent Retriever

January 01, 2014

Presentation

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Presenter: William A. Gray

December 02, 2013

Presentation TCT 2013

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

Presenter: Vivek Reddy

October 29, 2013

Presentation TCT 2013

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

Presenter: Ted Feldman

October 29, 2013

Presentation TCT 2013

The Need for Screening for Atrial Fibrillation

Presenter: David Albert

October 29, 2013

Presentation TCT 2013

Silent Atrial Fibrillation: An Under-Appreciated Threat

Presenter: Taya Glotzer

October 29, 2013

Presentation TCT 2013

Profile of Patients with Atrial Fibrillation in 2013: From the Highly Symptomatic Athlete to the Asymptomatic 85-Year-Old

Presenter: Mintu Turakhia

October 29, 2013

Presentation TCT 2013

Introduction: Multifaceted Approaches to Atrial Fibrillation: From Drugs to Ablation to Left Atrial Appendage Closure

Presenter: Vivek Reddy

October 29, 2013

Presentation TCT 2013

Acute Coronary Syndrome and Atrial Fibrillation: 1 + 1 = 5

Presenter: C. Michael Gibson

October 29, 2013

Advertisement

Cerebrovascular Events in 21,105 Patients with A-fib Randomized to Edoxaban Versus Warfarin

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

Clinical Decision Making in Stroke and Atrial Fibrillation (Including Closure Devices)

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

Timeliness, Revascularization Improve Endovascular Therapy Outcomes for Acute Stroke

Apixaban es Rentable comparado con Warfarina o Aspirina

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Cooling Protocol Feasible, Safe in Acute Stroke Patients

Balloon Guide Catheter Improves Acute Stroke Outcomes as Adjunct to Stent Retriever

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

The Need for Screening for Atrial Fibrillation

Silent Atrial Fibrillation: An Under-Appreciated Threat

Profile of Patients with Atrial Fibrillation in 2013: From the Highly Symptomatic Athlete to the Asymptomatic 85-Year-Old

Introduction: Multifaceted Approaches to Atrial Fibrillation: From Drugs to Ablation to Left Atrial Appendage Closure

Acute Coronary Syndrome and Atrial Fibrillation: 1 + 1 = 5

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content